GRHL2 and breast cancer: First, GRHL2 - a well-known regulator of morphogenesis that controls the differentiation and migration of epithelial cell layers - can maintain collective cell migration at its endogenous levels, drives MET when overexpressed, and enables EMT when knocked down in breast cancer cells [26, 27].